Keros Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 2.29 M | $46.64 M | -15.70% | 5.64% |
| VANGUARD GROUP INC | 01/29/2026 | 1.53 M | $31.06 M | -43.90% | 3.75% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 1.33 M | $27.17 M | 415.75% | 3.29% |
| STATE STREET CORP | 02/13/2026 | 1.08 M | $21.91 M | -17.42% | 2.65% |
| MADISON AVENUE PARTNERS, LP | 02/17/2026 | 823.71 K | $16.77 M | -69.58% | 2.03% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 804.21 K | $16.37 M | -21.06% | 1.98% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 783.92 K | $15.96 M | 158.61% | 1.93% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 768.43 K | $15.65 M | 26.58% | 1.89% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 755.47 K | $15.38 M | -43.26% | 1.86% |
| FEDERATED HERMES, INC. | 02/12/2026 | 654.72 K | $13.33 M | 27.34% | 1.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 635.21 K | $12.94 M | -24.14% | 1.56% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 591.69 K | $12.05 M | 282.47% | 1.46% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 590.52 K | $12.02 M | -55.45% | 1.45% |
| CITADEL ADVISORS LLC | 02/17/2026 | 472.52 K | $9.62 M | 168.26% | 1.16% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 360.42 K | $7.34 M | -70.77% | 0.89% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 321.35 K | $6.54 M | -4.12% | 0.79% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 318.44 K | $6.48 M | 285.88% | 0.78% |
| HRT FINANCIAL LP | 02/12/2026 | 260.89 K | $5.31 M | 509.57% | 0.64% |
| WEISS ASSET MANAGEMENT LP | 02/17/2026 | 254.06 K | $5.17 M | 100.00% | 0.63% |
| NORTHERN TRUST CORP | 02/17/2026 | 250.57 K | $5.10 M | -24.70% | 0.62% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 250.00 K | $5.09 M | 0.00% | 0.62% |
| MORGAN STANLEY | 02/13/2026 | 230.49 K | $4.69 M | -41.66% | 0.57% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 220.21 K | $4.48 M | 312.79% | 0.54% |
| CITADEL ADVISORS LLC | 02/17/2026 | 203.40 K | $4.14 M | 334.62% | 0.50% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 195.28 K | $3.98 M | 739.59% | 0.48% |
| ALGERT GLOBAL LLC | 02/17/2026 | 193.61 K | $3.94 M | 305.21% | 0.48% |
| MAN GROUP PLC | 02/17/2026 | 190.21 K | $3.87 M | -1.37% | 0.47% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 186.78 K | $3.80 M | -36.04% | 0.46% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 180.54 K | $3.68 M | -11.65% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 175.80 K | $3.58 M | -19.17% | 0.43% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 171.80 K | $3.50 M | 216.97% | 0.42% |
| JANE STREET GROUP, LLC | 02/12/2026 | 162.01 K | $3.30 M | -0.27% | 0.40% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 161.14 K | $3.28 M | 100.00% | 0.40% |
| NOMURA HOLDINGS INC | 02/17/2026 | 156.75 K | $3.19 M | 100.00% | 0.39% |
| BESSEMER GROUP INC | 02/05/2026 | 143.85 K | $2.93 M | 100.00% | 0.35% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 122.83 K | $2.50 M | 1.99% | 0.30% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 122.82 K | $2.50 M | 303.21% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 121.58 K | $2.48 M | 9.65% | 0.30% |
| Y-INTERCEPT (HONG KONG) LTD | 02/13/2026 | 117.36 K | $2.39 M | 141.76% | 0.29% |
| PDT PARTNERS, LLC | 02/17/2026 | 112.18 K | $2.28 M | -66.29% | 0.28% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 100.11 K | $2.04 M | -55.73% | 0.25% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 98.70 K | $2.01 M | 1,420.61% | 0.24% |
| UBS GROUP AG | 01/29/2026 | 97.08 K | $1.98 M | -6.53% | 0.24% |
| RANGELEY CAPITAL, LLC | 02/17/2026 | 96.80 K | $1.97 M | -62.57% | 0.24% |
| INVESCO LTD. | 02/19/2026 | 87.43 K | $1.78 M | 16.60% | 0.22% |
| RBF CAPITAL, LLC | 02/17/2026 | 81.72 K | $1.66 M | -45.52% | 0.20% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 80.77 K | $1.64 M | -13.18% | 0.20% |
| BARCLAYS PLC | 02/13/2026 | 74.73 K | $1.52 M | -24.60% | 0.18% |
| NUVEEN, LLC | 02/12/2026 | 63.10 K | $1.28 M | -16.82% | 0.16% |
| ENGINEERS GATE MANAGER LP | 02/17/2026 | 62.37 K | $1.27 M | 136.52% | 0.15% |
Keros Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 207 institutional investors and hedge funds held shares of Keros Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 2.29 M
VANGUARD GROUP INC: 1.53 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 1.33 M
STATE STREET CORP: 1.08 M
Madison Avenue Partners, LP: 823,707
ORBIMED ADVISORS LLC: 804,212
49.56% of Keros Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 23.46 M shares in the last 24 months. This purchase volume represents approximately $433.35 M in transactions.